Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy

被引：35

作者：

Dentali, F

Manfredi, E

Crowther, M

Ageno, W ^{[1
]}

机构：

[1] Univ Insubria, Varese, Italy

[2] McMaster Univ, Hamilton, ON, Canada

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 09期

关键词：

D O I：

10.1111/j.1538-7836.2005.01516.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2121 / 2123

页数：3

共 11 条

[1] The pharmacology and management of the vitamin K antagonists [J].

Ansell, J ;

Hirsh, J ;

Poller, L ;

Bussey, H ;

Jacobson, A ;

Hylek, E .

CHEST, 2004, 126 (03) :204S-233S

[2] A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome [J].

Crowther, MA ;

Ginsberg, JS ;

Julian, J ;

Denburg, J ;

Hirsh, J ;

Douketis, J ;

Laskin, C ;

Fortin, P ;

Anderson, D ;

Kearon, C ;

Clarke, A ;

Geerts, W ;

Forgie, M ;

Green, D ;

Costantini, L ;

Yacura, W ;

Wilson, S ;

Gent, M ;

Kovacs, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) :1133-1138

[3] PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOSIS SHOULD RECEIVE LONG-TERM ANTICOAGULANT TREATMENT [J].

DERKSEN, RHWM ;

DEGROOT, PG ;

KATER, L ;

NIEUWENHUIS, HK .

ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (09) :689-692

[4] A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS) [J].

Finazzi, G ;

Marchioli, R ;

Brancaccio, V ;

Schinco, P ;

Wisloff, F ;

Musial, J ;

Baudo, F ;

Berrettini, M ;

Testa, S ;

D'Angelo, A ;

Tognoni, G ;

Barbui, T .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) :848-853

[5] Medical progress: The antiphospholipid syndrome. [J].

Levine, JS ;

Branch, DW ;

Rauch, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) :752-763

[6]

Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26

[7] ANTIPHOSPHOLIPID THROMBOSIS - CLINICAL COURSE AFTER THE 1ST THROMBOTIC EVENT IN 70 PATIENTS [J].

ROSOVE, MH ;

BREWER, PMC .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (04) :303-308

[8] Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy [J].

Schulman, S ;

Svenungsson, E ;

Granqvist, S .

AMERICAN JOURNAL OF MEDICINE, 1998, 104 (04) :332-338

[9] Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism [J].

Wawrzynska, L ;

Tomkowski, WZ ;

Przedlacki, J ;

Hajduk, B ;

Torbicki, A .

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (02) :64-67

[10]

Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO

← 1 2 →